We are live on
!
Find out more
BCB
Brian C. Broderick Portfolio holdings
AUM
$542M
1-Year Est. Return
20.28%
This Fund
S&P 500
This Quarter
Est. Return
-12.6%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$330M
AUM Growth
-$61.7M
(-16%)
Cap. Flow
-$2.47M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
39.97%
Holding
75
New
–
Increased
15
Reduced
37
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$814K |
| 2 |
Nike
NKE
|
+$323K |
| 3 |
NVIDIA
NVDA
|
+$255K |
| 4 |
Honeywell
HON
|
+$175K |
| 5 |
Rockwell Automation
ROK
|
+$144K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$882K |
| 2 |
Becton Dickinson
BDX
|
+$339K |
| 3 |
Novartis
NVS
|
+$338K |
| 4 |
AbbVie
ABBV
|
+$317K |
| 5 |
Intel
INTC
|
+$259K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.32% |
| 2 | Technology | 23.27% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 7.94% |
| 5 | Consumer Staples | 6.09% |
Similar funds
MAM
GPWA
WCA
ISB
CIAM
FMC
HCM
FSA
Brian C. Broderick's Q2 2022 Portfolio in Review
As of Q2 2022, Brian C. Broderick held 75 positions worth $330M, down 16% from $391M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Brian C. Broderick's Q2 2022 filing shows 15 increased, 37 reduced and 4 closed positions. The largest sale was Unilever, an estimated $882K.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
- Brian C. Broderick added most to Medtronic in Q2 2022, an estimated $814K increase.
- Brian C. Broderick's biggest Q2 2022 reduction was Becton Dickinson, cutting an estimated $339K.
- Brian C. Broderick fully exited Unilever in Q2 2022, selling an estimated $882K.
- Brian C. Broderick's ten largest holdings make up 40% of its $330M portfolio in Q2 2022.
- Brian C. Broderick opened 0 new positions and closed 4 in Q2 2022.
- Brian C. Broderick's portfolio value fell 16% quarter-over-quarter to $330M.
Based on Brian C. Broderick's 13F filing for Q2 2022, filed 19 Jul 2022.